Sigli 2mg Tablet

Sigli 2mg Tablet is an oral antidiabetic medication specifically designed for adults diagnosed with type 2 diabetes mellitus. It plays a crucial role in conjunction with a balanced diet and regular exercise to effectively manage and control blood sugar levels. It is important to note that Glimepiride is not intended for the treatment of type 1 diabetes.

It belongs to the class of oral hypoglycaemic agents known as sulfonylureas. It acts by promoting the release of insulin from the beta cells in the pancreas, thereby facilitating the uptake and utilization of glucose by body cells.

The usual starting dose is 1 to 2 mg orally once a day, preferably taken with breakfast or the first main meal of the day. The maintenance dose may be adjusted, increasing in 1 or 2 mg increments, based on the individual's glycaemic response. The maximum daily dose should not exceed 8 mg. It's crucial to follow the prescribed dosage and any adjustments made by the healthcare provider.

Common side effects of Glimepiride include headaches, dizziness, weakness, nausea, and low blood sugar. It is imperative to seek medical attention promptly if any serious side effects such as pale or yellowed skin, dark coloured urine, confusion, weakness, or fever occur.

It should not be used in cases of diabetic ketoacidosis, and it is contraindicated in individuals with an allergy to sulfa drugs Patients with heart, liver, or kidney disease, as well as those with glucose6phosphate dehydrogenase deficiency, should exercise caution and inform their healthcare provider of their medical history.

If you forget to take a dose, try to take it as soon as you remember However, if it's nearing the time for your next scheduled dose, it's recommended to skip the missed dose and resume your regular dosing schedule. It's essential to avoid taking a double dose to make up for a missed one.